Pulmonary arteriovenous malformations (PAVMs) with feeding arteries of 3 mm or more have been shown to be associated with paradoxical embolization and serious neurologic complications. Therefore it is generally recommended to occlude feeding arteries of this size, while smaller feeding arteries often are left untreated. However, neurologic complications have also been described in patients with small PAVMs, and it has not been possible to stratify risk by size of feeding artery and thus there is no evidence that 3 mm is the critical size of the feeding artery potentially giving complications. Further, it is well-known that with time PAVMs and their feeding arteries may enlarge. Also, embolization of small feeding arteries will minimize the risk of paradoxical emboli and reduce the need for CT follow-up controls in these patients. Two cases demonstrate the possibility to embolize small feeding arteries.
Pulmonary arteriovenous malformations (PAVMs) with feeding arteries greater than 3 mm in diameter have been shown to be associated with paradoxical embolization and serious neurologic complications (1-3) with decreased oxygenation of the blood and risk of rupture of the PAVMs. Serious neurologic complications, including TIA, stroke, and brain abscess, occur in 30-40% of patients with PAVMs (4-8). Therefore, it is generally recommended to occlude feeding arteries of 3 mm to prevent paradoxical embolization, even in asymptomatic patients (1, 4, 6, 9-13), and as a consequence smaller feeding arteries are often left untreated. However, neurologic complications have also been described in patients with small PAVMs that were left untreated (9, 14, 15) and there is no evidence that 3 mm is the critical size of the feeding artery potentially giving complications, and it has not been possible to stratify risk by size of feeding artery (16) . It has been debated for many years what size of feeding arteries should be treated (15) , but the 3-mm guideline is still referred to in many articles describing PAVM treatment.
Further, it is well-known that with time PAVMs and their feeding arteries may enlarge (9, 10, 17), especially in growing children and after pregnancy.
Case 1
The first case report concerns a 40-year-old woman with hereditary hemorrhagic telangiectasia (HHT). Her father died from a probable cerebral attack. At screening of families with HHT the patient was discovered with PAVMs eight years previously. PaO 2 was then 9.7 kPa (72.8 mmHg), the contrast echocardiography showed a shunt of grade 4 (maximal), and the shunt was estimated to 24%. One big simple PAVM and two small PAVMs were visualized by pulmonary angiography (Fig. 1a and  b) . The big PAVM in right middle lobe was embolized with one detachable silicone balloon (Target Therapeutics, Fremont, CA, USA) (Fig. 2) while the two small ones were left untreated because of small feeders ,3 mm.
At follow-up 3 months later the PaO 2 had increased to 13.0 kPa (97.5 mmHg), the oxygenation was 98%, the contrast echocardiography shunt had decreased to 3, and the shunt was estimated to 7%. The patient felt better performance. In the following years there were no occurring problems, especially no neurologic events, but the patient experienced periodic headaches.
At follow-up 8 years later the CT scan showed that the big PAVM was occluded with a residual scar at the place of the former PAVM. At pulmonary angiography the balloon was invisible, but the embolized PAVM was without flow. The feeders of the other two PAVMs had since the initial pulmonary angiogram 8 years earlier grown from 1.6 mm to 2.7 mm (right lower lobe) ( Fig. 3) and from 1.5 mm to 2.0 mm (left upper lobe) (Fig. 4a) . The right sided PAVM was embolized using two vortexes -35, 3-5 mm, 0.035 coils (Boston Scientific/Target Vascular, La Garenne-Colombes, Cedex, France) ( Fig. 3b and c) , and the left with one 3/30 mm coil (MR eye, non-ferro-magnetic standard embolization coil 0.035, Cook, Bjaeverskov, Denmark) (Fig. 4b) .
Case 2
A 37-year-old woman, who was a member of a HHT family, had by screening been diagnosed with a PAVM in left lower lobe. At pulmonary angiography it appeared to be a complex PAVM (Fig. 5 ) with two feeding arteries: one was 4.4 mm in size (Fig. 6 ) and the other was 2 mm (Fig. 7) . It was decided 
Discussion
The aim of treating PAVMs is primarily to prevent paradoxical embolization especially to the brain, but also to prevent pleuro/pulmonary hemorrhage and to improve hypoxemia. The risk of paradoxical embolization is most probably greatest in high-flow PAVMs with big feeding arteries 3mm, but smaller feeding arteries also pose a risk (9, 14, 17). It makes no sense that septic emboli should not be able to enter the systemic circulation through smaller feeding vessels. It is not based on evidence that embolization of feeding arteries ,3 mm will prevent paradoxical embolization but common sense and published data tell that this is a possibility. Modern technology with the introduction of microcatheter systems and (detachable) microcoils also makes it more easy and safe to embolize smaller PAVMs, also below 2 mm diameter (Fig. 8) . The feeding arteries may grow, and occlusion will minimize the risk of paradoxical Reports of two cases and an 8-year follow-up without embolization emboli and reduce the need for follow-up controls to see if and when the PAVM reaches a size of 3 mm or more. Thus, the risk of lifelong recurrent exposure to ionizing radiation by CT is also reduced and embolization will also reduce the worry of the doctor and the patient. Therefore, embolization is suggested also of small feeders when technically feasible. 
